+8.5%
GSK vs ARWR
+17.3%
-8.8%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ARWR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.4% | +1.3% | -1.7% | -0.5% |
| 7D | +0.2% | -17.8% | +18.1% | +1.3% |
| 30D | +5.4% | -18.1% | +23.5% | +6.5% |
| 3M | +0.9% | -44.2% | +45.1% | +4.4% |
| 6M | +0.7% | -38.6% | +39.4% | +3.3% |
| YTD | +5.6% | -28.0% | +33.6% | +5.8% |
| 1Y | +8.5% | +16.1% | -7.6% | +5.1% |
| All | +8.5% | +17.3% | -8.8% | +5.1% |
Cumulative growth
Daily Returns
Daily percentage return beside ARWR.
Daily Out/Under-Performance
Portfolio return minus ARWR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ARWR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ARWR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling